Clinical trial
S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy…
NCT00068601 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00068601 |
|---|---|
| Title | S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer |
| Official title | Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH Cancer and Leukemia Group B Eastern Cooperative Oncology Group ETOP IBCSG Partners Foundation |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer, Infertility, Menopausal Symptoms |
| Intervention type | Drug |
| Interventions | cyclophosphamide, goserelin acetate |
| Enrollment | 257 |
| Start date | Oct 1, 2003 |
| Primary completion | Jan 1, 2014 |
| Completion | Sep 1, 2016 |
| First posted | Sep 11, 2003 |
| Last update posted | Dec 30, 2019 |
| Countries | Australia, Belgium, Hungary, Italy, New Zealand, Switzerland |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: